Market Tracker

09/20 5:16pm ET

Mylan NV (NASDAQ:MYL)

31.39
Delayed Data
As of 4:00pm ET
 +0.41 / +1.32%
Today’s Change
29.39
Today|||52-Week Range
45.87
-17.72%
Year-to-Date

Today’s Trading

Previous close30.98
Today’s open31.12
Day’s range30.95 - 31.69
Volume6,279,901
Average volume (3 months)6,146,100
Market cap$16.6B
Dividend yield--
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-6.95%
Earnings growth (next 5 years)+3.21%
Revenue growth (last year)+17.44%
P/E ratio13.5
Price/Sales1.79
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+0.47+0.51%
PRGOPerrigo Company PLC+0.18+0.21%
JAZZJazz Pharmaceuticals...-3.11-2.06%
ALNYAlnylam Pharmaceutic...+38.80+51.71%
Data as of 4:14pm ET, 09/20/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.20
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts